| MolName | 2-[3-[(E)-(1-cyclohexyl-2,4,6-trioxo-1,3-diazinan-5-ylidene)methyl]indol-1-yl]-N-(oxolan-2-ylmethyl)acetamide |
| MolecularFormula | C26H30N4O5 |
| Smiles | O=C(Cn1c(cccc2)c2c(/C=C(\C(NC(N2C3CCCCC3)=O)=O)/C2=O)c1)NCC1OCCC1 |
| InChI | InChI=1S/C26H30N4O5/c31-23(27-14-19-9-6-12-35-19)16-29-15-17(20-10-4-5-11-22(20)29)13-21-24(32)28-26(34)30(25(21)33)18-7-2-1-3-8-18/h4-5,10-11,13,15,18-19H,1-3,6-9,12,14,16H2,(H,27,31)(H,28,32,34)/t19-/m1/s1 |
| InChIK | WVADNXANAVHIPR-LJQANCHMSA-N |
| TotalMolweight | 478.547 |
| Molweight | 478.547 |
| MonoisotopicMass | 478.221621 |
| CLogP | 1.6213 |
| CLogS | -3.961 |
| H Acceptors | 9 |
| H Donors | 2 |
| TotalSurfaceArea | 358.09 |
| Relative PSA | 0.26669 |
| PolarSurfaceArea | 109.74 |
| Druglikeness | 0.40378 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | high |
| Irritant | none |
| Nasty Functions | twice activated DB |
| Shape Index | 0.51429 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 1 |
| Rotatable Bond | 6 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 9 |
| Sp3Atoms | 13 |
| Symmetricatoms | 2 |
| Amides | 3 |
| Aromatic Nitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - 2-[3-[(E)-(1-cyclohexyl-2,4,6-trioxo-1,3-diazinan-5-ylidene)methyl]indol-1-yl]-N-(oxolan-2-ylmethyl)acetamide | 2 - 2-[3-[(E)-(1-cyclohexyl-2,4,6-trioxo-1,3-diazinan-5-ylidene)methyl]indol-1-yl]-N-(oxolan-2-ylmethyl)acetamide